Retrospective and Prospective Observational Study of MRI Changes in Bone and Visceral Lesions of Patients With Type 1 Gaucher Disease Treated With VPRIV® (Velaglucerase Alfa)
Clinical trial NCT03333447 · COMPLETED
Trial details
- NCT number
- NCT03333447
- Sponsor
- CEN Biotech
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-01-17
- Primary completion
- 2017-09-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.